Eupraxia Pharmaceuticals logo

Eupraxia Pharmaceuticals Share Price (NASDAQ: EPRX)

$5.4

0.13

(2.47%)

Last updated on

Check the interactive Eupraxia Pharmaceuticals Stock chart to analyse performance

Eupraxia Pharmaceuticals stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$5.20
    Today's High:$5.40

    Day's Volatility :3.7%

  • 52 Weeks Low:$2.20
    52 Weeks High:$6.20

    52 Weeks Volatility :64.52%

Eupraxia Pharmaceuticals Stock Returns

PeriodEupraxia Pharmaceuticals IncIndex (Russel 2000)
3 Months
35.03%
0.0%
6 Months
35.17%
0.0%
1 Year
104.62%
0.0%
3 Years
80.34%
-4.7%

Eupraxia Pharmaceuticals Inc Key Stats

Check Eupraxia Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$5.27
Open
$5.2
Today's High
$5.4
Today's Low
$5.2
Market Capitalization
$189.5M
Today's Volume
$17.6K
52 Week High
$6.1999
52 Week Low
$2.2
Revenue TTM
$0.0
EBITDA
$-29.0M
Earnings Per Share (EPS)
$-0.86
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-169.25%

Stock Returns calculator for Eupraxia Pharmaceuticals Stock including INR - Dollar returns

The Eupraxia Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Eupraxia Pharmaceuticals investment value today

Current value as on today

₹2,12,976

Returns

₹1,12,976

(+112.98%)

Returns from Eupraxia Pharmaceuticals Stock

₹1,07,692 (+107.69%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Eupraxia Pharmaceuticals Stock

-33%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Eupraxia Pharmaceuticals Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Eupraxia Pharmaceuticals Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Eupraxia Pharmaceuticals(by analysts ranked 0 to 5 stars)

Eupraxia Pharmaceuticals Share Price Target

What analysts predicted

Upside of 117.59%

Target:

$11.75

Current:

$5.40

Eupraxia Pharmaceuticals share price target is $11.75, a slight Upside of 117.59% compared to current price of $5.40 as per analysts' prediction.

Eupraxia Pharmaceuticals Stock Insights

  • Price Movement

    In the last 1 year, EPRX stock has moved up by 108.6%

Eupraxia Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Eupraxia Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Eupraxia Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Eupraxia Pharmaceuticals Inc logo
-1.48%
35.17%
104.62%
80.34%
80.34%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. The company's proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. Its lead product candidates include EP-104IAR, which is in Phase III clinical trial for the treatment of unmet medical needs and pain relief for knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
Organization
Eupraxia Pharmaceuticals
Employees
33
CEO
Dr. James A. Helliwell FRCPC, M.D.
Industry
Miscellaneous

Key Management of Eupraxia Pharmaceuticals Inc

NameTitle
Dr. James A. Helliwell FRCPC, M.D.
CEO & Director
Dr. Amanda Malone Ph.D.
Chief Scientific Officer & COO
Mr. Paul Anthony Brennan B.Sc., M.Sc.
Chief Business Officer
Dr. Mark M. Kowalski M.D., Ph.D.
Chief Medical Officer
Mr. Alexander John Rothwell Eng., M.B.A.
Chief Financial Officer

Important FAQs about investing in EPRX Stock from India :

What is Eupraxia Pharmaceuticals share price today?

Eupraxia Pharmaceuticals share price today is $5.40 as on at the close of the market. Eupraxia Pharmaceuticals share today touched a day high of $5.40 and a low of $5.20.

What is the 52 week high and 52 week low for Eupraxia Pharmaceuticals share?

Eupraxia Pharmaceuticals share touched a 52 week high of $6.20 and a 52 week low of $2.20. Eupraxia Pharmaceuticals stock price today i.e. is closed at $5.40, lower by 12.9% versus the 52 week high.

How to invest in Eupraxia Pharmaceuticals Stock (EPRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Eupraxia Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eupraxia Pharmaceuticals Shares that will get you 0.2778 shares as per Eupraxia Pharmaceuticals share price of $5.40 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Eupraxia Pharmaceuticals Stock (EPRX) from India?

Indian investors can start investing in Eupraxia Pharmaceuticals (EPRX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Eupraxia Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Eupraxia Pharmaceuticals share’s latest price of $5.40 as on August 30, 2025 at 1:29 am IST, you will get 1.8519 shares of Eupraxia Pharmaceuticals. Learn more about fractional shares .

What are the returns that Eupraxia Pharmaceuticals has given to Indian investors in the last 5 years?

Eupraxia Pharmaceuticals stock has given 80.34% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?